Concepedia

Matthew Kulke

MK

3

Publications

113

Citations

3

H-Index

2009

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Massachusetts General Hospital

University of Toronto

Matthew Kulke is an author at Dana-Farber Cancer Institute specializing in cancer research, medicine, and surgical oncology.

Top concepts

Publications per year

2009–2015

3

Publications

3

Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis

Penelope A. Bradbury, Rihong Zhai, Clement Ma et al. · Clinical Cancer Research · 2009 · 58 citations · Full text

<i>p53 Arg72Pro</i> and <i>MDM2 T309G</i> Polymorphisms, Histology, and Esophageal Cancer Prognosis

David W. Cescon, Penelope A. Bradbury, Kofi Asomaning et al. · Clinical Cancer Research · 2009 · 41 citations · Full text

A randomized open-label phase II study of Everolimus alone or in combination with Pasireotide LAR in advanced, progressive pancreatic neuroendocrine tumors (pNET): COOPERATE-2 trial

Matthew Kulke, P. Ruszniewski, Eric Van Cutsem et al. · 2015 · 14 citations

, , +10

Rows per page

1–3 of 3